The combined chemotherapy of ifosfamide plus vindesine and cisplatin in advanced non-small cell lung cancer
- VernacularTitle:异环磷酰胺、长春酰胺和顺铂联合治疗晚期非小细胞肺癌
- Author:
Shicong HUANG
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
Regimen;
Chemotherapy
- From:
Journal of Chongqing Medical University
1986;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05).The median duration of survival was eight months.The major toxicity was the inhibition of bone marrow,especially of leukocyte and platelet.Leukopenia and thrombocytopenia often appeared at day 8～12.Conlusion:The combined chemotherapy of ifosfamide plus vindesine and cisplatin is effective in advanced non-small cell lung cancer including the returm cases,and the toxicity is tolerable.If G-CSF is used as a complementary therapy,this regimen could be quite clinically valuable.
